mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.099 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.068 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.02 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |